Enquiry/Quote
Apomorphine Hydrochloride Injection bulk supplier for pharma manufacturers

Apomorphine Hydrochloride Injection Suppliers & Bulk Manufacturers

Available Forms: Injection

Available Strengths: 10 mg/mL, 20 mg/mL

Reference Brands: Apokyn (USA)

Category: Neurology

Apomorphine Hydrochloride Injection is available in Injection and strengths such as 10 mg/mL, 20 mg/mL. Sourced from GMP-certified and ISO-compliant manufacturers, this API meets global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical formulation and commercial manufacturing, Apomorphine Hydrochloride Injection is supplied in bulk quantities with complete regulatory support including DMF, COA, and MSDS.

Technical Specifications & Supply Details
Lead Time 7 to 60 days (depending on batch size & schedule)
MOQ As per manufacturer’s batch size
COA Available with every batch
Regulatory Dossier / DMF Available upon request
Export Documentation FSC, COA, Manufacturing License, Product Permission
Standards IP, BP, USP
Certifications WHO-GMP, EU-GMP, USFDA (as applicable)

Apomorphine Hydrochloride Injection can be exported to over 30 countries across Asia, Africa, Europe, and Latin America. Flexible packaging, competitive pricing, and a verified supplier network make Pharmatradz a trusted sourcing partner for pharmaceutical companies and contract manufacturers worldwide.

Get Enquiry / Request Bulk Quote

Quick Response Guaranteed | Verified Suppliers

📘 Sourcing Guide

Product Description:

Apomorphine Hydrochloride, marketed under the brand name Apokyn, is a synthetic aporphine derivative that functions primarily as a non-selective dopamine agonist. It activates D2-like dopamine receptors and, to a lesser extent, D1-like receptors, making it effective in the management of motor symptoms associated with advanced Parkinson’s disease. Additionally, apomorphine exhibits antagonistic activity at 5-HT2 and α-adrenergic receptors, contributing to its overall pharmacological profile.

Although historically derived from morphine through chemical modification, apomorphine does not contain morphine, does not share its opioid structure, and does not bind to opioid receptors. Its name reflects its origin as a morphine decomposition product rather than any opioid activity. Apomorphine is used clinically to provide rapid relief of “off” episodes in Parkinson’s disease patients, restoring mobility and reducing symptoms such as bradykinesia, rigidity, and tremor. Administered subcutaneously or as a sublingual film, it acts quickly to improve motor function and is typically used under strict medical supervision due to potential side effects like nausea, hypotension, and sedation.

Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'

The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Back to Listing

Frequently Asked Questions

Apomorphine Hydrochloride is used in the management of advanced Parkinson’s disease, specifically for the acute, intermittent treatment of “off” episodes when motor function suddenly deteriorates. It helps improve mobility, reduce bradykinesia, rigidity, and tremor in patients already receiving dopaminergic therapy.

Apomorphine Hydrochloride is a synthetic dopamine agonist formulated as the hydrochloride salt for stability and effective subcutaneous or sublingual administration.

Apomorphine Hydrochloride is marketed under trade names such as Apokyn in the USA and Kynmobi in the EU.

Apomorphine Hydrochloride is manufactured by multiple pharmaceutical companies worldwide, including originator and generic manufacturers that supply hospital and regulated markets.

The generic name of the product is apomorphine hydrochloride.

Common brand names include Apokyn and Kynmobi.

Apomorphine Hydrochloride is manufactured in GMP-compliant facilities in the USA, Europe, and other regulated markets for clinical use in Parkinson’s disease management.

Yes, Apomorphine Hydrochloride Injection is available with DMF and other regulatory documents such as COA and MSDS. These can be provided upon request for qualified buyers.

Absolutely. Sample requests are accepted for formulation trials and quality checks. Please submit an enquiry to initiate the process.

Our manufacturing partners are GMP-certified and comply with ISO and WHO standards, ensuring global quality benchmarks.

Lead times vary based on quantity and destination, but most orders are fulfilled within 1–3 weeks. Express shipping options are available.

Yes, Apomorphine Hydrochloride Injection is exported to over 30 countries across Asia, Africa, Europe, and Latin America. We support documentation for customs and regulatory clearance.

Related Products

Opicapone

Strength:
25 mg, 50 mg

Form: Capsules

Reference Brands: Ongentys (USA/EU)

View Details
Primidone

Strength:
50 mg , 250 mg

Form: Tablets, Capsules

Reference Brands: Mysoline (USA)

View Details
Pyridostigmine Bromide

Strength:
60 mg, 90 mg,180 mg

Form: Tablets

Reference Brands: Mestinon (USA)

View Details
Mecamylamine Hydrochloride

Strength:
2.5 mg, 5 mg,10 mg

Form: Tablets

Reference Brands: Vecamyl (USA/EU)

View Details
Enquire Now

Quick Response Guaranteed | Verified Suppliers

Subscribe to Our Newsletter

Stay updated on pharma trends and marketplace opportunities.

Please enter the correct answer.
This website uses cookies to ensure you get the best experience. By using our site, you agree to our Privacy Policy.